European Society of Cardiology
Skip navigation links
Home
About the ESC
Membership
Communities
Congresses
Education
Guidelines & Surveys
Journals
Initiatives
Welcome to the European Society of Cardiology. Our mission: to reduce the burden of cardiovascular disease in Europe
 

2008 ESC Congress - Munich

Press Releases published during the ESC Congress 2008

Additional press releases from the Press Book are available here.

If you would like to contact an ESC spokesperson to comment on a story or an issue, contact the Press Office or call +33 (0)4 92 94 86 27.  

10/09/2008 00:00:00

 ESC Congress 2008 Press releases


DateTitle
02 Sep 2008Fibrin-Derived Peptide FX06 Reduces Cardiac Reperfusion Injury
02 Sep 2008Safety of the Factor Xa Inhibitor, Apixaban, in Combination with Antiplatelet Therapy after Acute Coronary Syndrome: Results of the APPRAISE-I Dose Guiding Trial
02 Sep 2008Overcoming Poor Response to Standard Oral Antiplatelet Agents
02 Sep 2008Results From the SEAS (Simvastatin and Ezetimibe in Aortic Stenosis) Study
02 Sep 2008Myocardial Regeneration by Intracoronary Infusion of Selected Population of Stem Cells in Acute Myocardial Infarction (REGENT) Randomized Multicenter Trial
02 Sep 2008The Effects of the Direct Lipoprotein-Associated Phospholipase A2 Inhibitor Darapladib on Human Coronary Athlerosclerotic Plaque
02 Sep 2008Pre-Hospital Treatment on the Way to Percutaneous Coronary Intervention
02 Sep 2008Networks for Life
02 Sep 2008ST Elevation Infarction
02 Sep 2008Heart Failure Implementation
02 Sep 2008New European Guidelines for the Management of Acute Pulmonary Embolism
02 Sep 2008The Role Played by Drug-Eluting Stents in Reducing Mortality in AMI
01 Sep 2008Impact of School Based Programs
01 Sep 2008Robotic Navigation Systems in Electrophysiology
01 Sep 2008Biomarkers For Ischaemia and Necrosis - Simple Blood Tests to Detect Myocardial Infarction
01 Sep 2008Fluvastatin XL Use is Associated With Improved Cardiac Outcome After Major Vascular Surgery. Results From a Randomized Placebo Controlled Trial: DECREASE III
01 Sep 2008New Generation Drug-Eluting Stent Demonstrates Equivalent Efficacy to Market Leader in ‘Real World’ Study
01 Sep 2008New Diagnostic Tools and Biomarkers
01 Sep 2008Transcatheter Aortic Valve Replacement – A New Frontier in Cardiovascular Medicine
01 Sep 2008Transapical Aortic Valve Implantation
01 Sep 2008Primary Prevention of Coronary Heart Disease: Challenges and Achievements
01 Sep 2008Does Treatment of Depression Improve Prognosis After Heart Attack?
01 Sep 2008Intima Media Thickness of the Carotid Artery
01 Sep 2008Antiangiogenic and Anti-Inflammatory Drugs: Are They Safe?
01 Sep 2008Issues on Cholesterol: Diet, Statins and Genetics
01 Sep 2008Percutaneous Mitral Valve Repair
01 Sep 2008Advances in the Management of Patients with Diabetes Mellitus: Triumphs and Tragedies
31 Aug 2008Effects of n-3 PUFA in Patients With Symptomatic Chronic Heart Failure
31 Aug 2008TIME-CHF Trial: Elderly HF Patients Do Not Benefit From Intensive Medical Therapy
31 Aug 2008With the BEAUTIFUL Results, Procoralan* (ivabradine) is the First Antianginal Treatment Shown to Reduce Myocardial Infarction (Heart Attack) and Revascularisation in Stable Coronary Patients
31 Aug 2008New Molecular Imaging Techniques Aim at Detection of Earliest Steps of Disease Development and Therapy Response
31 Aug 2008Ongoing Debate: The Future of Non-Invasive Cardiac Imaging
31 Aug 2008Computed Tomography Provides Anatomy – We Need Ischemia!
31 Aug 2008Cardiac Ultrasound Imaging Goes Handheld
31 Aug 2008DES: New Elements in the Debate
31 Aug 2008Best Use of Drug-Eluting Stents: When Should They be Avoided?
31 Aug 2008Who Needs Surgery?
31 Aug 2008Sports-Related Sudden Cardiac Death is Reduced by Pre-Participation Cardiovascular Screening
31 Aug 2008Positive Exercise Testing in Athletes: What Does That Mean?
31 Aug 2008Should We Use Echocardiography to Screen Young Athletes?
31 Aug 2008Genetic Testing?
31 Aug 2008Global Study Shows Telmisartan Reduces Outcome of Cardiovascular Death, Heart Attack or Stroke
31 Aug 2008The GISSI-HF Trial: Effects of Rosuvastatin in 4,574 Patients with Chronic Heart Failure
31 Aug 2008DES in Diabetic Patients
 
Highlight On
Receive My ESC News